Aceves, Jeffrey O.
Heja, Szilvia
Kobayashi, Kenichi
Robinson, Sanlin S.
Miyoshi, Tomoya
Matsumoto, Takuya
Schäffers, Olivier J. M.
Morizane, Ryuji http://orcid.org/0000-0002-0377-5667
Lewis, Jennifer A. http://orcid.org/0000-0002-0280-2774
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (TR002155)
NIH NCATS Tissue Chips 2.0 Consortium
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (TR002155)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (UC2DK126023)
NIH NCATS Tissue Chips 2.0 Consortium NIDD (Re)Building a Kidney Consortium
Article History
Received: 4 April 2022
Accepted: 26 August 2022
First Online: 2 September 2022
Competing interests
: Dr. Lewis has been funded by F. Hoffman-La Roche AG, Inc. and AstraZeneca, Inc. Dr. Lewis and Dr. Morizane serve on the Scientific Advisory Board of Trestle Biotherapeutics, which has licensed technology from their labs. The other authors declare no potential conflict of interest.